With advanced instruments and state-of-the-art multivariate data analyses, Microbiosci is capable to offer effective solutions for metabolomics, thereby, achieving the specific goals for diverse research.
— Microbosci, the division of Creative Biogene, which is one of the world’s leading high quality products and satisfactory services providers in order to facilitate the investigation of microbial researches, recently announces the release of its microbial metabolomics services. With advanced instruments and state-of-the-art multivariate data analyses, Microbiosci is capable to offer effective solutions for metabolomics, thereby, achieving the specific goals for diverse research.
Microbial interactions and cellular functions can be better explained by integrating biological information into systemic microbiology. Therefore, microbial metabolomics has become an important part of systems biology. Microbial metabolomics is generally considered to be the most straightforward method of performing quantitative measurements related to the physiological state of a microorganism. In recent years, research on microbial physiology by metabolomics has received increasing attention.
Microbiosci developed microbial metabolomics services cover both targeted metabolomics and non-targeted metabolomics, and designed the complete process from our initial consultation to the generation of metabolomics data.
As a leading provider of high quality targeted metabolomics services, Microbosci has years of experience in the quantitative measurement of target metabolic compounds using high pressure liquid chromatography (HPLC) and mass spectrometry (MS). Microbosci provides target metabolic pathways and target metabolite analysis services to identify and quantify target small molecules in organisms with shorter turnaround time and competitive price guaranteed. Microbiosci has a wide range of target metabolic pathways and target metabolite analysis services for professional and comprehensive targeted metabolomics research in the field of pharmaceutical and academic research.
Meanwhile, the state-of-the-art facilities with experienced scientists in Microbosci provide unparalleled expertise in non-target metabolomics analysis. Moreover, a variety of options are available to get to save time and cost of discovery. Microbiosci conducts non-target metabolomics research for partners in the pharmaceutical and academic research fields, which includes research on cross-disease indications from in vitro models to clinical studies.
“Microbial metabolomics service is the best choice to process the research in microbiology field.” said Marcia Brady, the marketing director of Creative Biogene, “There is no need to choose every single process step in different platform, Microbosci offers a simple way to get the whole microbial metabolomics service. Moreover, we can offer customized solutions based on your specific requirements with years of experience and professionalism as always.”
Microbiosci, as the division of Creative Biogene, is always dedicated to satisfying the needs of clients covering more than 50 countries and districts. As a leading custom service provider in delivering medicine microbiology solutions, Microbiosci has become a well-recognized industry leader with years of experience and professional scientists.
Release ID: 88929689